首页> 外国专利> ANTITUMOR BENZOXAZINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION METHOD THEREOF

ANTITUMOR BENZOXAZINE DERIVATIVES HAVING INHIBITORY ACTIVITY AGAINST HISTONE DEACETYLASE AND PREPARATION METHOD THEREOF

机译:具有组氨酸去乙酰化的抑制活性的反苯甲嗪衍生物及其制备方法

摘要

PURPOSE: Benzoxazine derivatives and a preparation method thereof are provided, which compounds have inhibitory activity against histone deacetylase which removes an acetyl group from the lysine tail in the N-terminal of histone to selectively induce the terminal differentiation of the tumor cells, so that the compounds can effectively inhibit growth of tumor cells. CONSTITUTION: The benzoxazine derivatives represented by formula (1) are provided, wherein R1 is aryl, heteroaryl or C3-C8 cycloaryl which is optionally substituted with one or more substituents selected from hydroxy, halogen, alkyloxy, alkyl, amino, alkylamino, carboxyl, nitro, amide and sulfone in which the heteroaryl contains one or more elements selected from nitrogen, sulfur and oxygen in a ring; R2 is hydrogen or arylalkyl; A is O, S, CH2, sulfone(SO2), sulfoxide(SO), CONH, NHCO, NX or NXSO2 in which X is hydrogen, C1-5 alkyl or independently the same as R1; and n is 0, 1, 2 or 3. The method for preparing compounds of formula (2) comprises the steps of: (a) acylation reacting 2-bromo arylalkyl carboxylic acid of formula (6) with hydroxyamino benzoic ester of formula (7) in aprotic solvent to prepare compounds of formula (8); (b) cyclization of the compounds of formula (8) in the presence of inorganic salt to prepare benzoxazine ester of formula (9); (c) treating the benzoxazine ester of formula (9) with hydroxide salt to prepare an organic acid of formula (10); (d) acylation reacting the organic acid of formula (10) with the protected hydroxyl amine in aprotic solvent to prepare compounds of formula (11); and (e) hydrogenating the compounds of formula (11) in the presence of palladium, wherein Y is O, S, CH2, SO2, SO or NX.
机译:目的:提供苯并恶嗪衍生物及其制备方法,该化合物对组蛋白脱乙酰酶具有抑制活性,该酶从组蛋白N端赖氨酸尾部去除乙酰基,选择性诱导肿瘤细胞的终末分化。化合物可有效抑制肿瘤细胞的生长。组成:提供了由式(1)表示的苯并恶嗪衍生物,其中R1为芳基,杂芳基或C3-C8环芳基,其任选地被一个或多个选自羟基,卤素,烷氧基,烷基,氨基,烷基氨基,羧基,硝基,酰胺和砜,其中杂芳基在环中包含一种或多种选自氮,硫和氧的元素; R 2是氢或芳基烷基; A为O,S,CH 2,砜(SO 2),亚砜(SO),CONH,NHCO,NX或NXSO 2,其中X为氢,C 1-5烷基或独立地与R 1相同; n为0、1、2或3。制备式(2)化合物的方法包括以下步骤:(a)使式(6)的2-溴芳基烷基羧酸与式(7)的羟氨基苯甲酸酯进行酰化反应。 )在非质子溶剂中制备式(8)化合物; (b)在无机盐的存在下环化式(8)的化合物以制备式(9)的苯并恶嗪酯; (c)用氢氧化盐处理式(9)的苯并恶嗪酯,以制备式(10)的有机酸; (d)在非质子传递溶剂中使式(10)的有机酸与被保护的羟基胺反应,进行酰化,以制备式(11)的化合物; (e)在其中Y为O,S,CH 2,SO 2,SO或NX的钯存在下氢化式(11)化合物。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号